Multicentre prospective longitudinal study of multiple sclerosis patients treated with ocrelizumab
Latest Information Update: 30 Nov 2023
At a glance
- Drugs Ocrelizumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
Most Recent Events
- 30 Nov 2023 New trial record